Literature DB >> 19845595

Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients.

T F Wang1, T Wang, R Altman, P Eshaghian, J P Lynch, D J Ross, J A Belperio, S S Weigt, R Saggar, A Gregson, B Kubak, R Saggar.   

Abstract

We report five cases of possible drug-induced periostitis associated with long-term use of voriconazole therapy after lung transplantation (LT). The diagnosis of periostitis was made by the documentation of bone pain, elevation of serum alkaline phosphatase and characteristic findings on radionuclide bone imaging in the absence of any identifiable rheumatologic disease. This periostitis appears similar to hypertrophic osteoarthopathy (HOA) but does not meet all criteria for HOA. In all patients, the symptoms resolved rapidly after discontinuation of voriconazole therapy. Awareness of this potential syndrome, which manifests as bone pain, elevated serum alkaline phosphatase and a bone scan suggestive of periostitis, is necessary in LT recipients on long-term voriconazole.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19845595     DOI: 10.1111/j.1600-6143.2009.02837.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  26 in total

1.  Voriconazole metabolism, toxicity, and the effect of cytochrome P450 2C19 genotype.

Authors:  Dimitrios Zonios; Hiroshi Yamazaki; Norie Murayama; Ven Natarajan; Tara Palmore; Richard Childs; Jeff Skinner; John E Bennett
Journal:  J Infect Dis       Date:  2014-01-07       Impact factor: 5.226

2.  Voriconazole-induced periostitis.

Authors:  Christine Rossier; Vincent Dunet; Frederic Tissot; Berengère Aubry-Rozier; Oscar Marchetti; Olivier Marchetti; Ariane Boubaker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-06       Impact factor: 9.236

3.  Voriconazole-Induced Periostitis Deformans: A Mimicker of Hypertrophic Pulmonary Osteoarthropathy.

Authors:  Karim Ladak; Laurence Rubin
Journal:  Clin Med Res       Date:  2017-05-09

Review 4.  An update on drug-induced arthritis.

Authors:  Marwan H Adwan
Journal:  Rheumatol Int       Date:  2016-03-21       Impact factor: 2.631

5.  Voriconazole-induced periostitis: beyond post-transplant patients.

Authors:  Joshua D Reber; Gavin A McKenzie; Stephen M Broski
Journal:  Skeletal Radiol       Date:  2016-03-15       Impact factor: 2.199

6.  Voriconazole-induced periostitis deformans: serial imaging in a patient with ANCA vasculitis.

Authors:  S Cormican; N Adams; P O'Connell; A McErlean; D de Freitas
Journal:  Skeletal Radiol       Date:  2017-09-02       Impact factor: 2.199

7.  Painful periostitis in the setting of chronic voriconazole therapy.

Authors:  Margaret Skaug; Cedric Spak; Umesh Oza
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-10

8.  Plasma fluoride level as a predictor of voriconazole-induced periostitis in patients with skeletal pain.

Authors:  Woo J Moon; Erica L Scheller; Anupam Suneja; Jacob A Livermore; Anurag N Malani; Varsha Moudgal; Lisa E Kerr; Eric Ferguson; David M Vandenberg
Journal:  Clin Infect Dis       Date:  2014-07-03       Impact factor: 9.079

9.  Voriconazole-induced periostitis in two post-transplant patients.

Authors:  Matthew D Bucknor; Andrew J Gross; Thomas M Link
Journal:  J Radiol Case Rep       Date:  2013-08-01

10.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.